Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, British Columbia, Nov. 01, 2023 -- Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will...
/PRNewswire/ -- The "Global Antibody Drug Conjugates (ADC) Market by Product (Kadcyla, Enhertu, Padcev, Polivy), Linker Type (Cleavable, Non-Cleavable),...
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have been assigned an average recommendation of “Hold” from the seven analysts that are covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price […]
Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus rating of “Hold” from the seven brokerages that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price […]
In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into.